Pacific Biosciences Q3 Revenues Jump 83%, Says Sequel II/IIe Installations At All-Time High
Pacific Biosciences of California Inc (NASDAQ:PACB) reported Q3 sales of $34.9 million, beating the consensus of $33.23 million and up…
Pacific Biosciences Q3 EPS $0.08 Up From $(0.14) YoY, Sales $34.90M Beat $33.23M Estimate
Pacific Biosciences (NASDAQ:PACB) reported quarterly earnings of $0.08 per share. This is a 157.14 percent increase over losses of $(0.14) per share from the same period last year. The company reported quarterly sales
The Daily Biotech Pulse: Pfizer Reports Solid Q3 Earnings, Regulatory Setback For Legend, Lilly to Supply Additional COVID-19 Antibody Cocktails To US
Here's a roundup of top developments in the biotech space over the last 24 hours:
Earnings Scheduled For November 2, 2021
Companies Reporting Before The Bell
• Thomson Reuters (NYSE:TRI) is expected to report quarterly earnings at $0.48 per share on revenue of $1.86 billion.
Cathie Wood’s ARK Invest Posts Fund Purchases For Friday, Oct. 29, 2021: NTLA, PACB, ACHR, MKFG, BLDE, FB, CDNA, DOC, EXAS, VERV, BEAM
Intellia Therapeutics (NTLA) - 34,200
Pacific Biosciences of California (PACB) - 119,183
Archer Aviation (ACHR) - 591,618
MarkForged Holding Corp (MKFG) - 76,612
Blade
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected.
Class Of 2010: A Decade After Their IPOs, Where Are These Companies Now?
Initial public offerings provide companies with the wherewithal to pursue growth opportunities without having to bear the burden of repayment.
Cathie Wood’s ARK Invest Posts Fund Purchases For Tuesday, Oct. 5, 2021: TDOC, PACB, BEAM, SGFY, TWOU, DNA, SSYS, MKFG, ACHR, BLDE, VLD, NIU, SQ, VUZI, ADPT, SURF, QSI, SLGC, MASS, DYNS, PATH, HOOD, TOST, PRNT
Teladoc Health (TDOC) - 154,175 Shares
Pacific Biosciences Of California (PACB) - 783,580
Beam Therapeutics (BEAM) - 104,491
Signify Health (SGFY) - 749,117
2U (TWOU) - 166,427
Gingko Bioworks (DNA) -
Cathie Wood’s ARK Invest Posts Fund Purchases For Thursday, Sept. 30, 2021: BEAM, DNA, AVAV, ACHR, PD, TWOU, VCYT, QSI, SURF, MASS, PACB, DYNS, BLDE
Beam Therapeutics (BEAM) - 130,645 Shares
Gingko Bioworks (DNA) - 173,518
AeroVironment (AVAV) - 16,200
Archer Aviation (ACHR) - 95,564
PagerDuty (PD)
2U (TWOU) - 12,749
Veracyte (VCYT) - 6,478
Quantum-Si (QSI)
